Merck news in 2026: 29 dated events
The latest Merck event on this page is dated Oct 29, 2026. cnbc.com reported: Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength.
Get Merck's live signals in Claude or ChatGPT, or by API
What changed at Merck this week? Use Autobound signals for merck.com.- Dated events
- 29
- Last 90 days
- 14
- Latest
- Oct 29, 2026
Source: Autobound Signal API · 92 signals tracked for Merck · updated
News · latest 10
Latest Merck news
Showing 10 of 29 dated events. The Signal API returns all of them.
Get them with one API call- Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strengthMerck reported third-quarter revenue of $18.09 billion, up 5% year-over-year.
- Merck to Acquire Silence Therapeutics for $1.3 Billion, Expanding Rare Disease Portfolio with siRNA InnovationMerck entered into a definitive agreement to acquire Silence Therapeutics for approximately $1.3 billion in equity value.
- Merck Commits $2.9 Billion to Montgomery County ExpansionMerck plans to invest $2.9 billion to expand its pharmaceutical research and manufacturing operations in Montgomery County by the end of 2030.
- Merck unveils $500M research building at West Point campus in Montgomery CountyMerck is investing $50 million in its research and development facilities at Spring House Innovation Park in Lower Gwynedd, Pennsylvania.
- Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to makeMerck officially opened a new 120,000-square-foot research and development facility named Advance on its West Point, Pennsylvania campus.
- Paul J. Diaz Elected to Merck BoardPaul J. Diaz, Member of the Board of Directors
- Merck reports trial results. Scotiabank raises target for Merck stockMerck & Co. reported positive phase 2b trial results for its drug candidate tulisokibart, with the high-dose group achieving a 72% response rate compared to 35% for placebo.
- MSD backs Ingenia as sole phase 3 TIE2 eye drug advances in Korea and US - CHOSUNBIZWith Ingenia Therapeutics
- Merck (MRK) Stock May Be 37% Undervalued On Fresh FDA ApprovalMerck recently received approval for its treatment WINREVAIR.
Showing 10 of 29 dated events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Merck with the Signal API
One POST /v1/companies/enrich call with merck.com returns Merck news signals (news), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"merck.com","signal_types":["news"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.
Same industry
News at related companies
Questions about Merck news
What is the latest news on Merck?
What is going on with Merck?
Is Merck laying off employees?
Page updated , the date of the newest row on this page.
Source. News articles about the company, one source link per event.
Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.
Data as of .